nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0572	0.0572	CcSEcCtD
Atazanavir—Atrioventricular block complete—Hydrochlorothiazide—nephrolithiasis	0.0468	0.0468	CcSEcCtD
Atazanavir—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0269	0.0269	CcSEcCtD
Atazanavir—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0244	0.0244	CcSEcCtD
Atazanavir—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0242	0.0242	CcSEcCtD
Atazanavir—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0213	0.0213	CcSEcCtD
Atazanavir—Gout—Hydrochlorothiazide—nephrolithiasis	0.0175	0.0175	CcSEcCtD
Atazanavir—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0173	CcSEcCtD
Atazanavir—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0171	CcSEcCtD
Atazanavir—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0159	0.0159	CcSEcCtD
Atazanavir—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0149	CcSEcCtD
Atazanavir—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0148	CcSEcCtD
Atazanavir—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0148	CcSEcCtD
Atazanavir—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0137	CcSEcCtD
Atazanavir—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0136	CcSEcCtD
Atazanavir—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Atazanavir—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0135	CcSEcCtD
Atazanavir—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0134	CcSEcCtD
Atazanavir—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0133	CcSEcCtD
Atazanavir—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.013	0.013	CcSEcCtD
Atazanavir—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Atazanavir—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Atazanavir—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0123	CcSEcCtD
Atazanavir—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Atazanavir—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Atazanavir—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Atazanavir—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0112	CcSEcCtD
Atazanavir—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Atazanavir—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Atazanavir—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Atazanavir—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0105	CcSEcCtD
Atazanavir—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Atazanavir—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.01	0.01	CcSEcCtD
Atazanavir—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00958	0.00958	CcSEcCtD
Atazanavir—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00947	0.00947	CcSEcCtD
Atazanavir—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00944	0.00944	CcSEcCtD
Atazanavir—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00936	0.00936	CcSEcCtD
Atazanavir—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00933	0.00933	CcSEcCtD
Atazanavir—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00925	0.00925	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00906	0.00906	CcSEcCtD
Atazanavir—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00898	0.00898	CcSEcCtD
Atazanavir—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00896	0.00896	CcSEcCtD
Atazanavir—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00891	0.00891	CcSEcCtD
Atazanavir—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00888	0.00888	CcSEcCtD
Atazanavir—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00876	0.00876	CcSEcCtD
Atazanavir—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00871	0.00871	CcSEcCtD
Atazanavir—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.0082	0.0082	CcSEcCtD
Atazanavir—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00816	0.00816	CcSEcCtD
Atazanavir—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00808	0.00808	CcSEcCtD
Atazanavir—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00776	0.00776	CcSEcCtD
Atazanavir—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00765	0.00765	CcSEcCtD
Atazanavir—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00725	0.00725	CcSEcCtD
Atazanavir—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00704	0.00704	CcSEcCtD
Atazanavir—Tension—Hydrochlorothiazide—nephrolithiasis	0.00701	0.00701	CcSEcCtD
Atazanavir—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00699	0.00699	CcSEcCtD
Atazanavir—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00694	0.00694	CcSEcCtD
Atazanavir—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00691	0.00691	CcSEcCtD
Atazanavir—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00663	0.00663	CcSEcCtD
Atazanavir—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00656	0.00656	CcSEcCtD
Atazanavir—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00653	0.00653	CcSEcCtD
Atazanavir—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00644	0.00644	CcSEcCtD
Atazanavir—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0064	0.0064	CcSEcCtD
Atazanavir—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00631	0.00631	CcSEcCtD
Atazanavir—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00628	0.00628	CcSEcCtD
Atazanavir—Cough—Hydrochlorothiazide—nephrolithiasis	0.00623	0.00623	CcSEcCtD
Atazanavir—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00608	0.00608	CcSEcCtD
Atazanavir—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00608	0.00608	CcSEcCtD
Atazanavir—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00608	0.00608	CcSEcCtD
Atazanavir—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00606	0.00606	CcSEcCtD
Atazanavir—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00601	0.00601	CcSEcCtD
Atazanavir—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00595	0.00595	CcSEcCtD
Atazanavir—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00588	0.00588	CcSEcCtD
Atazanavir—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00583	CcSEcCtD
Atazanavir—Shock—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00573	CcSEcCtD
Atazanavir—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00563	0.00563	CcSEcCtD
Atazanavir—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00556	0.00556	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00531	CcSEcCtD
Atazanavir—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00527	0.00527	CcSEcCtD
Atazanavir—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0052	0.0052	CcSEcCtD
Atazanavir—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00518	CcSEcCtD
Atazanavir—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00513	CcSEcCtD
Atazanavir—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00507	CcSEcCtD
Atazanavir—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00503	CcSEcCtD
Atazanavir—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00498	0.00498	CcSEcCtD
Atazanavir—Pain—Hydrochlorothiazide—nephrolithiasis	0.00498	0.00498	CcSEcCtD
Atazanavir—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.0048	0.0048	CcSEcCtD
Atazanavir—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00477	0.00477	CcSEcCtD
Atazanavir—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00463	CcSEcCtD
Atazanavir—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00461	0.00461	CcSEcCtD
Atazanavir—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00461	0.00461	CcSEcCtD
Atazanavir—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00429	CcSEcCtD
Atazanavir—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00418	CcSEcCtD
Atazanavir—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00412	0.00412	CcSEcCtD
Atazanavir—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00399	0.00399	CcSEcCtD
Atazanavir—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00385	CcSEcCtD
Atazanavir—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00371	CcSEcCtD
Atazanavir—Rash—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00368	CcSEcCtD
Atazanavir—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00367	0.00367	CcSEcCtD
Atazanavir—Headache—Hydrochlorothiazide—nephrolithiasis	0.00365	0.00365	CcSEcCtD
Atazanavir—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00346	CcSEcCtD
